Deriving actionable strategies to enhance cancer immunotherapy response

癌症免疫疗法是一种越来越常见的治疗方法，用于治疗几种类型的晚期癌症。虽然它可以在少数患者中显着有效，但许多患者对治疗没有反应，我们预测谁不会受益的能力有限。该项目旨在研究接受免疫治疗的患者的肿瘤免疫学的不同方面，以确定更好的预测因子和更广泛有效的免疫治疗策略。

Cancer immunotherapy is an increasingly common treatment used to treat several types of advanced cancers. Whilst it can be dramatically effective in a minority of patients, many patients do not respond to the treatment and our ability to predict who will not benefit is limited. This project aims to study distinct aspects of tumour immunology in patients receiving immunotherapy treatments in order to identify better predictors and more widely-effective immunotherapy treatment strategies.